About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: May 27, 2009
FDA’s Non-Guidance on Relating Risk Information is FDA’s Loss – Industry’s Opportunity
This week, the FDA issued a Draft Guidance on Presenting Risk Information in Prescription Drug and Medical Device Promotion. It is more accurately referred to as a Non-Guidance. According to FDA's DDMAC, the Internet has not really taken hold yet. … Continue reading
Posted in New and Social Media
Comments Off on FDA’s Non-Guidance on Relating Risk Information is FDA’s Loss – Industry’s Opportunity